Rights and permissions
About this article
Cite this article
Cladribine: increased risk of secondary lung cancer. Inpharma Wkly. 1427, 21 (2004). https://doi.org/10.2165/00128413-200414270-00051
Published:
Issue Date:
DOI: https://doi.org/10.2165/00128413-200414270-00051